NCT05140928

Brief Summary

The aim of our study is to assess the effect of giving dadiah as a supplement to pregnant women on improving the growth and digestive health of children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 20, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 18, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 2, 2021

Completed
Last Updated

December 2, 2021

Status Verified

December 1, 2021

Enrollment Period

1.1 years

First QC Date

November 18, 2021

Last Update Submit

December 1, 2021

Conditions

Keywords

dadiahlocal yogurtMinangkabau yogurtpregnant womendietary supplementgut microbiotaimmunoglobulin Agastrointestinal healthfermented dairy productlactic acid bacteriachild growthprobiotic

Outcome Measures

Primary Outcomes (4)

  • Infant fecal gut microbiota proportion

    Relative difference of non-pathogen and pathogen to total bacteria in infant fecal sample

    three months

  • Breast milk gut microbiota proportion

    Relative difference of non-pathogen and pathogen to total bacteria in infant fecal sample

    three months

  • Level of infant fecal secretory Immunoglobulin A

    Concentration of secretory Immunoglobulin A in infant fecal sample

    three months

  • Level of breastmilk secretory Immunoglobulin A

    Concentration of secretory Immunoglobulin A in breastmilk sample

    three months

Secondary Outcomes (3)

  • Weight increment

    three months

  • Length increment

    three months

  • Head circumferences increment

    three months

Study Arms (2)

Dadiah Pudding

ACTIVE COMPARATOR

The mother received 1 cup or 100 g dadiah pudding containing 75-gram dadiah which provide ±260 kcal energy, 6.12g protein, 23.31g fat, 6.49g carbohydrate, and 6.1x 109 CFU/ml lactic acid bacteria.

Other: Dadiah Pudding

Pudding without dadiah

PLACEBO COMPARATOR

The mother received 1 cup or 100 g pudding without dadiah containing ±75 kcal energy, 0.3g protein, 0.45 g fat, and 16.2g carbohydrate.

Other: Pudding without Dadiah

Interventions

Supplementation of Dadiah Pudding to pregnant women. One cup a day for 18-26 weeks of pregnancy

Also known as: Minangkabau Yogurt Pudding
Dadiah Pudding

Supplementation of Milk Pudding without dadiah to pregnant women. One cup a day for 18-26 weeks of pregnancy

Also known as: Milk Pudding
Pudding without dadiah

Eligibility Criteria

Age20 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women with10-20 weeks gestation
  • Women give voluntary informed consent
  • Women willing to give exclusive breastfeeding
  • Women live in an area under study, registered, and visit antenatal care at targeted public health centers
  • Women plan to deliver babies in the area under study

You may not qualify if:

  • Women having a medical history of HIV/AIDS, TBC, Hepatitis B.
  • Women with multiple pregnancies
  • Women having obesity, and/or another high-risk pregnancy (hypertension, preeclampsia, diabetes, bleeding history)
  • Received antibiotic treatment or intentionally consumes probiotic products during the preceding 4 weeks. (If the subject was on antibiotics before the beginning of the study or probiotics, a washout period of 2 weeks is required.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zuhrah Taufiqa

Padang, West Sumatra, 25144, Indonesia

Location

Related Publications (12)

  • Rinita Amelia, Koshy Philip, Yudha Endra Pratama EP. Characterization and probiotic potential of lactic acid bacteria isolated from dadiah sampled in West Sumatra. Food Sci Technol. 2020

    BACKGROUND
  • Taufiqa Z, Chandra DN, Helmizar H, Lipoeto NI, Hegar B. Micronutrient Content and Total Lactic Acid Bacteria of Dadiah Pudding as Food Supplementation for Pregnant Women. 2021;9:1149-55

    BACKGROUND
  • Collado MC, Surono IS, Meriluoto J, Salminen S. Potential probiotic characteristics of Lactobacillus and Enterococcus strains isolated from traditional dadih fermented milk against pathogen intestinal colonization. J Food Prot. 2007 Mar;70(3):700-5. doi: 10.4315/0362-028x-70.3.700.

  • Surono IS. Traditional Indonesian dairy foods. Asia Pac J Clin Nutr. 2015;24 Suppl 1:S26-30. doi: 10.6133/apjcn.2015.24.s1.05.

  • Surono IS, Martono PD, Kameo S, Suradji EW, Koyama H. Effect of probiotic L. plantarum IS-10506 and zinc supplementation on humoral immune response and zinc status of Indonesian pre-school children. J Trace Elem Med Biol. 2014 Oct;28(4):465-9. doi: 10.1016/j.jtemb.2014.07.009. Epub 2014 Aug 2.

  • Mantaring J, Benyacoub J, Destura R, Pecquet S, Vidal K, Volger S, Guinto V. Effect of maternal supplement beverage with and without probiotics during pregnancy and lactation on maternal and infant health: a randomized controlled trial in the Philippines. BMC Pregnancy Childbirth. 2018 May 31;18(1):193. doi: 10.1186/s12884-018-1828-8.

  • Robertson RC. The Gut Microbiome in Child Malnutrition. Nestle Nutr Inst Workshop Ser. 2020;93:133-144. doi: 10.1159/000503352. Epub 2020 Jan 28.

  • Swartwout B, Luo XM. Implications of Probiotics on the Maternal-Neonatal Interface: Gut Microbiota, Immunomodulation, and Autoimmunity. Front Immunol. 2018 Dec 3;9:2840. doi: 10.3389/fimmu.2018.02840. eCollection 2018.

  • Chen Y, Li Z, Tye KD, Luo H, Tang X, Liao Y, Wang D, Zhou J, Yang P, Li Y, Su Y, Xiao X. Probiotic Supplementation During Human Pregnancy Affects the Gut Microbiota and Immune Status. Front Cell Infect Microbiol. 2019 Jul 16;9:254. doi: 10.3389/fcimb.2019.00254. eCollection 2019.

  • Baldassarre ME, Di Mauro A, Mastromarino P, Fanelli M, Martinelli D, Urbano F, Capobianco D, Laforgia N. Administration of a Multi-Strain Probiotic Product to Women in the Perinatal Period Differentially Affects the Breast Milk Cytokine Profile and May Have Beneficial Effects on Neonatal Gastrointestinal Functional Symptoms. A Randomized Clinical Trial. Nutrients. 2016 Oct 27;8(11):677. doi: 10.3390/nu8110677.

  • Prakoeswa CRS, Herwanto N, Prameswari R, Astari L, Sawitri S, Hidayati AN, Indramaya DM, Kusumowidagdo ER, Surono IS. Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Benef Microbes. 2017 Oct 13;8(5):833-840. doi: 10.3920/BM2017.0011. Epub 2017 Oct 12.

  • Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14. doi: 10.1038/nrgastro.2014.66. Epub 2014 Jun 10.

MeSH Terms

Conditions

Growth Disorders

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Zuhrah Taufiqa, MD

    Indonesia University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants are randomly assigned to two groups; the intervention group that received dadiah pudding and the control group that received pudding without dadiah in parallel for the duration of the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 18, 2021

First Posted

December 2, 2021

Study Start

August 20, 2020

Primary Completion

September 9, 2021

Study Completion

September 9, 2021

Last Updated

December 2, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations